Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-19T07:36:55.172Z Has data issue: false hasContentIssue false
  • English
  • Français

Emergence of Coagulase Negative Staphylococci as Major Nosocomial Bloodstream Pathogens

Published online by Cambridge University Press:  02 January 2015

Richard I. Stillman ,
Richard P. Wenzel  and
Leigh C. Donowitz
Richard I. Stillman
Affiliation:
Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia Department of Internal Medicine, Cornell University Medical Center, New York, New York Department of Medicine, University of Iowa, Iowa City, Iowa
Richard P. Wenzel
Affiliation:
Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia Department of Internal Medicine, Cornell University Medical Center, New York, New York Department of Medicine, University of Iowa, Iowa City, Iowa
Leigh C. Donowitz*
Affiliation:
Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia Department of Internal Medicine, Cornell University Medical Center, New York, New York Department of Medicine, University of Iowa, Iowa City, Iowa
*
Department of Pediatrics, Box 386, University of Virginia, School of Medicine, Charlottesville, VA 22908
Get access Rights & Permissions [Opens in a new window]

Abstract

Over an eight year period, 1975 to 1982, 1,843 nosocomial bloodstream infections were identified by routine prospective surveillance at the University of Virginia Hospital (106/10,000 admissions). Despite a decline in overall bloodstream infection rates during the study period (P =.085), bloodstream infections due to gram positive organisms increased from 29 (1975-1978) to 43/10,000 (1979-1982), (P<0.001). Notably, rates for coagulase negative staphylococci increased from 5.2 (1975-1978) to 12.4/10,000 (1979-1982), (P<0.001). In 1982, coagulase negative staphylococci accounted for 17% of all bloodstream infections and were the most frequently isolated pathogens. Sixty-four percent of patients with coagulase negative staphylococci were in critical care units versus 41% with other bloodstream infections (P<.05). The recognition of coagulase negative staphylococci as significant bloodstream pathogens markedly alters the clinician's approach to nosocomial septicemia.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 8 , Issue 3 , March 1987 , pp. 108 - 112
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1987

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Dixon, RE: Effect of infections on hospital care. Ann Intern Med 1978; 89:749–753.Google Scholar
2.Center for Disease Control. National nosocomial infections study report, 1977. Atlanta OA, Center for Disease Control, 1979: pp 1–3.Google Scholar
3.Wenzel, RP, Osterman, CA, Townsend, TR, el al: Development of a statewide program for surveillance and reporting of hospital-acquired infections. J Infect Dis 1979; 140:741–746.CrossRefGoogle ScholarPubMed
4.Centers for Disease Control. Nosocomial infection surveillance 1980-82, in CDC Surveillance Summaries 1983, 32 (No 4SS).Google Scholar
5.Wenzel, RP, Osterman, CA, Donowitz, LG, et al: Identification of procedure related nosocomial infections in high risk patients. Rev Infect Dis 1981; 3:701–707.CrossRefGoogle ScholarPubMed
6.Rose, R, Hunting, KJ, Townsend, TR, et al: The morbidity, mortality and economics of hospital-acquired bloodstream infections: A controlled study. South Med J 1977; 70:1267–1269.Google Scholar
7.Freeman, J, Rosner, B, McGowan, J Jr: Adverse effects of nosocomial infections. J Infect Dis 1979; 140:732–740.Google Scholar
8.Neu, HC: Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother 1974; 6:177–182.Google Scholar
9.Goto, S: In vitro and in vivo antibacterial activity of moxalactain; an oxa-β-lactam antibiotic. Rev Infect Dis 1982; 4(suppl):S501–S510.Google Scholar
10.Grieble, HG, Krause, SL, Pappas, SA, et al: The prevalence of high-level methicillin resistance in multiply resistant hospital staphylococci. Medicine 1981; 60:62–69.CrossRefGoogle ScholarPubMed
11.Christensen, CD, Bisno, AL, Parisi, JT: Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med 1982; 96:1–10.CrossRefGoogle ScholarPubMed
12.Wade, JC, Schimpff, SC, Newman, KA: Staphylococcus epidermidis: An increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982; 98:503–508.CrossRefGoogle Scholar
13.Lowder, JN, Lazarus, HM, Herzig, RH: Bacteremias and fungemias in oncologic patients with central venous catheters, changing spectrum of infection. Arch Intern Med 1982; 142:1456–1459.CrossRefGoogle ScholarPubMed
14.Winston, DJ, Dudnick, DV, Chapin, M, el al: Coagtdase-Negative Staphylococcal bacteremia in patients receiving imimosuppresive therapy. Arch Intern Med 1983; 143:32–36.CrossRefGoogle ScholarPubMed
15.Forse, RA, Dixon, C, Bernard, K: Staphylococcus epidermidis: An important pathogen. Surgery 1979: 86:507–514.Google ScholarPubMed
16.Sitges-Scrra, A, Puig, P, Jaurrieta, E, et al: Catheter sepsis due to Staphylococcus epidermidis during parenteral nutrition. Surg Gynecol Obstet 1980; 151:481–483.Google Scholar
17.Malmvall, BE, Aleslig, K, Dottori, O. et al: Septicemia in patients with central venous catheters. Acta Chir Scand 1980; 146:155–159.Google Scholar
18.Goldmann, DA, Durbin, WA Jr, Freeman, J: Nosocomial infections in a neonatal intensive care unit. J Infect Dis 1981; 144:449–459.CrossRefGoogle Scholar
19.Battisti, O, Mitchison, R, Davies, PA: Changing blood culture isolates in a referral neonatal intensive care unit. Arch Dis Child 1981; 56:775–778.CrossRefGoogle Scholar
20.Voting, LS: Infection in the compromised host. Hasp Pract 1981; 16:73–84.Google Scholar
21.Haley, CE, Gregory, WW, Donowitz, LG, Wenzel, RP: Neonatal intensive care unit (NICU) bloodstream infections (BSI): Emergence of gram-positive bacteria as major pathogens. 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Miami Beach. Florida. October 1982.Google Scholar
22.Byron, WB Jr, Hollander, M: Statistics, A Biomedical Introduction. New York, John Wiley & Sons, 1977.Google Scholar
23.Maki, D, Zilz, M, Alvarado, E, et al: Multiply-resistant Staphylococcus epidermidis surgical wound infections linked to a chronic carrier, abstracted. Am J Infect Control 1982; 10:114.Google Scholar
24.Liekweg, WG, Greenfield, LJ: Vascular prosthetic infections: Collected experience and results of treatment. Surgery 1977; 81:335.Google Scholar
25.Kamme, C, Lindberg, L: Aerobic and anaerobic bacteria in deep infections after total hip orthroplasty: Differential diagnosis. Clin Orthop, Jan-Feb 1981, pp 201–207.Google Scholar
26.Shurtdeff, DB, Foltz, EL, Weeks, RD, el al: Therapy of Staphylococcus epidermidis: Infections associated with cerebrospinal shunts. Pediatrics 1974; 53:55–62.Google Scholar
27.Williams, M, Dawson, JE, Geuniwell, CG: Urinary infection with coagulase negative staphylococcus in patients undergoing prostatectomy. J Clin Pathol 1980; 33:702–703.Google Scholar
28.Bender, JW, Hughes, WT: Fatal Staphylococcia epidermis sepsis following bone marrow transplantation. Johns Hopkins Med J 1980; 146:13–15.Google Scholar
29.Males, BM, Rogers, WA Jr, Parisi, JT: Virulence factors of biotypes of Staphylococcus epidermidis from clinical sources. J Clin Microbiol 1975; 1:256–261.Google Scholar
30.Andriole, VT, Lyons, RW: Coagulase-negative staphylococcus. Ann NY Acad Sci 1970; 174:533–544.Google Scholar
31.Keys, TF, Hewitt, WL: Endocarditis due to micrococci and Staphylococcus epidermidis. Arch Intern Med 1973; 132:216–220.Google Scholar
32.Finland, M, Barnes, MW: Changing etiology of bacterial endocarditis in the antibacterial era. Ann Intern Med 1970; 72:341–348.Google Scholar
33.Dismukes, WE, Karchmer, AW, Buckley, MJ, et al: Prosthetic valve endocarditis. Circulation 1973; 48:365–377.Google Scholar
34.Speller, DCE, Mitchell, RG: Coagulase negative staphylococci causing endocarditis after cardiac surgery. J Clin Pathol 1973; 26:517–522.CrossRefGoogle ScholarPubMed
35.Schoenbaum, SC, Gardner, P, Shillito, J: Infection of cerebrospinal fluid shunts: Epidemiology, clinical manifestations, and therapy. J Infect Dis 1975; 131:543–552.Google Scholar
36.Bailey, RR: Significance of coagulase-negative staphylococcus in urine. J Infect Dis 1973; 127:179–182.Google Scholar
37.Ponce de Leon, S, Wenzel, RP: Hospital acquired bloodstream infections with Staphylococcus epidermidis: Review of 100 cases. Am J Med 1984; 77(4):639–644.Google Scholar
38.Stamm, WE: Infections related to medical devices. Ann Intern Med 1978; 89:764–769.Google Scholar
39.Haley, RW, Culver, DH, Hooton, TM, et al: The efficacy of infection surveillance and control programs in preventing nosocomial infections in U.S. hospitals. Amer J Epidemiol 1985; 121:182–205.Google Scholar
40.Karchmer, AW, Archer, GL, Dismukes, WE: Staphylococcus epidermidis causing prosthetic valve endocarditis: Microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983; 98:447–455.Google Scholar